company background image
A086900

Medy-Tox KOSDAQ:A086900 Stock Report

Last Price

₩131.00k

Market Cap

₩743.5b

7D

12.0%

1Y

-8.9%

Updated

09 Dec, 2022

Data

Company Financials +
A086900 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance0/6
Financial Health6/6
Dividends2/6

A086900 Stock Overview

Medy-Tox Inc. operates as a biopharmaceutical company in South Korea.

Medy-Tox Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Medy-Tox
Historical stock prices
Current Share Price₩131,000.00
52 Week High₩150,400.00
52 Week Low₩99,700.00
Beta0.88
1 Month Change18.98%
3 Month Change5.99%
1 Year Change-8.91%
3 Year Change-50.25%
5 Year Change-65.94%
Change since IPO918.19%

Recent News & Updates

Recent updates

Tread With Caution Around Medy-Tox Inc.'s (KOSDAQ:086900) 0.4% Dividend Yield

Apr 02
Tread With Caution Around Medy-Tox Inc.'s (KOSDAQ:086900) 0.4% Dividend Yield

A Look At Medy-Tox's (KOSDAQ:086900) Share Price Returns

Feb 09
A Look At Medy-Tox's (KOSDAQ:086900) Share Price Returns

Read This Before Buying Medy-Tox Inc. (KOSDAQ:086900) For Its Dividend

Dec 18
Read This Before Buying Medy-Tox Inc. (KOSDAQ:086900) For Its Dividend

Shareholder Returns

A086900KR BiotechsKR Market
7D12.0%-0.8%-4.4%
1Y-8.9%-41.0%-24.1%

Return vs Industry: A086900 exceeded the KR Biotechs industry which returned -41% over the past year.

Return vs Market: A086900 exceeded the KR Market which returned -24.1% over the past year.

Price Volatility

Is A086900's price volatile compared to industry and market?
A086900 volatility
A086900 Average Weekly Movement5.7%
Biotechs Industry Average Movement8.0%
Market Average Movement6.5%
10% most volatile stocks in KR Market11.6%
10% least volatile stocks in KR Market3.8%

Stable Share Price: A086900 is not significantly more volatile than the rest of KR stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: A086900's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000577Hyun-Ho Junghttps://www.medy-tox.co.kr

Medy-Tox Inc. operates as a biopharmaceutical company in South Korea. It provides botulinum toxin products, including Neuronox, a lyophilized white power for injection that is used to treat foot deformities due to spasticity in pediatric cerebral palsy patients; INNOTOX, a colorless transparent liquid-filled injection that is used to temporarily improve moderate to severe glabellar wrinkles; and Coretox, a lyophilized white power for injection that is used to temporarily improve moderate to severe glabellar wrinkles. The company also offers hyaluronic acid filler products comprising Neuramis and Potenfill that are tissue recovering biomaterials.

Medy-Tox Inc. Fundamentals Summary

How do Medy-Tox's earnings and revenue compare to its market cap?
A086900 fundamental statistics
Market Cap₩743.48b
Earnings (TTM)₩23.21b
Revenue (TTM)₩182.05b

33.6x

P/E Ratio

4.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
A086900 income statement (TTM)
Revenue₩182.05b
Cost of Revenue₩72.86b
Gross Profit₩109.19b
Other Expenses₩85.98b
Earnings₩23.21b

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)3.90k
Gross Margin59.98%
Net Profit Margin12.75%
Debt/Equity Ratio27.9%

How did A086900 perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

27%

Payout Ratio